Similar articles

• [Subcutaneous heparin in prevention of post-operative thrombosis].

  Godal HC, Stormorken H. Godal HC, et al. Tidsskr Nor Laegeforen. 1976 Sep 10;96(25):1332-3. Tidsskr Nor Laegeforen. 1976. PMID: 968875 Norwegian. No abstract available.
• [Low doses subcutaneously administered heparin as thrombosis prevention in surgery].

  van Vroonhoven TJ. van Vroonhoven TJ. Ned Tijdschr Geneeskd. 1976 Jan 24;120(4):159-63. Ned Tijdschr Geneeskd. 1976. PMID: 1107860 Review. Dutch. No abstract available.
• [Oral anticoagulants, dextran or low-dose subcutaneous heparin: which is it to be in the prophylaxis of deep vein thrombosis of operated patients? (author's transl)].

  Verstraete M. Verstraete M. Przegl Lek. 1977;34(10):777-9. Przegl Lek. 1977. PMID: 594414 Polish. No abstract available.
• Thrombosis prophylaxis in visceral surgery with the low molecular weight heparin fragment Kabi 2165 (7,500 and 2,500 anti-Xa IU/day).

  Koller M, Schoch U, Buchmann P, Largiadèr F, von Felten A, Frick PG. Koller M, et al. Haemostasis. 1986;16 Suppl 2:69-70. doi: 10.1159/000215583. Haemostasis. 1986. PMID: 3527887 Clinical Trial. No abstract available.
• [Prevention of thrombosis: current status and prospects].

  Neri Serneri GG. Neri Serneri GG. Cardiol Prat. 1976 Jul-Dec;27(2):71-6. Cardiol Prat. 1976. PMID: 829041 Review. Italian. No abstract available.